Sites not expected to fade away even as DCTs continue to grow past COVID-19.
Arnab Roy
Advertisement
Arnab Roy is a leader in ZS’s R&D excellence practice area and leads the development and global commercialization of ZS's DCT strategy and analytics solutions.
Articles by Arnab Roy
Identifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.
Assessing the opportunities, considerations and implications of decentralized trials—and why they’re here to stay
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
2
Answering the Sustainability Call: Digital Health Technologies and eCOA
3
KRI Overload: When More Isn’t Better
4
Enhancing Data Quality and Real-World Evidence in Clinical Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
